Quest Diagnostics Company Insiders

DGX Stock  USD 163.89  2.57  1.59%   
Quest Diagnostics' insiders are aggressively selling. The analysis of insiders' sentiment of trading Quest Diagnostics Incorporated stock suggests that vertually all insiders are panicking at this time. Quest Diagnostics employs about 50 K people. The company is managed by 29 executives with a total tenure of roughly 173 years, averaging almost 5.0 years of service per executive, having 1724.14 employees per reported executive.
Stephen Rusckowski  CEO
CEO and President Director and Member of Executive Committee
Daniel Stanzione  Chairman
Non-Executive Chairman of the Board

Quest Diagnostics' Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-11-06Michael J DeppeDisposed 18755 @ 154.05View
2024-10-28Karthik KuppusamyDisposed 1775 @ 156.92View
2024-08-28Karthik KuppusamyDisposed 1990 @ 153.26View
2024-07-24Mark E DelaneyDisposed 420 @ 143.08View
2024-04-29Karthik KuppusamyDisposed 1760 @ 140View
2024-04-04Earl BlumenauerDisposed @ 131.5
2024-02-29Michael E PrevoznikDisposed 5611 @ 125.88View
2024-02-28Catherine T DohertyDisposed 5557 @ 126.57View
2024-02-23Vicky B GreggDisposed 2500 @ 126.64View
2024-02-22Michael E PrevoznikDisposed 661 @ 126.14View
Monitoring Quest Diagnostics' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Quest Diagnostics Incorporated. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Quest Diagnostics' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Quest Diagnostics' future performance. Based on our forecasts, it is anticipated that Quest will maintain a workforce of slightly above 50000 employees by December 2024.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

Quest Diagnostics' latest congressional trading

Congressional trading in companies like Quest Diagnostics, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Quest Diagnostics by those in governmental positions are based on the same information available to the general public.
2024-05-04Representative Earl BlumenauerAcquired Under $15KVerify
2024-02-14Senator Tommy TubervilleAcquired $15K to $50KVerify
2024-02-13Senator Tommy TubervilleAcquired $15K to $50KVerify
2024-01-03Senator Thomas R CarperAcquired Under $15KVerify
2024-01-02Senator Thomas R CarperAcquired Under $15KVerify

Quest Diagnostics Management Team Effectiveness

The company has Return on Asset of 0.0566 % which means that on every $100 spent on assets, it made $0.0566 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1322 %, implying that it generated $0.1322 on every 100 dollars invested. Quest Diagnostics' management efficiency ratios could be used to measure how well Quest Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.14 in 2024. Return On Capital Employed is likely to drop to 0.10 in 2024. At this time, Quest Diagnostics' Other Assets are fairly stable compared to the past year. Asset Turnover is likely to rise to 0.99 in 2024, whereas Total Assets are likely to drop slightly above 8.5 B in 2024.
Common Stock Shares Outstanding is likely to rise to about 128 M in 2024, whereas Net Income Applicable To Common Shares is likely to drop slightly above 758.9 M in 2024.

Quest Diagnostics Workforce Comparison

Quest Diagnostics Incorporated is rated # 2 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 267,869. Quest Diagnostics retains roughly 50,000 in number of employees claiming about 19% of equities under Health Care industry.

Quest Diagnostics Profit Margins

The company has Net Profit Margin of 0.09 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.14 %, which entails that for every 100 dollars of revenue, it generated $0.14 of operating income.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.440.32
Significantly Up
Pretty Stable

Quest Diagnostics Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Quest Diagnostics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Quest Diagnostics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Quest Diagnostics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-12-01
0.8889
8
9
 19,228 
 39,285 
2024-09-01
1.0
7
7
 33,054 
 71,616 
2024-06-01
14.0
14
1
 13,868 
 1,760 
2024-03-01
0.8286
29
35
 270,540 
 42,779 
2023-09-01
1.3333
4
3
 444.00 
 4,099 
2023-03-01
1.0714
30
28
 325,415 
 86,031 
2022-12-01
0.4615
12
26
 76,674 
 153,117 
2022-09-01
0.8
8
10
 6,686 
 31,658 
2022-06-01
0.7826
18
23
 446,378 
 870,746 
2022-03-01
0.9231
24
26
 429,415 
 111,141 
2021-12-01
0.3333
2
6
 37,853 
 75,130 
2021-09-01
0.6429
9
14
 201,285 
 400,134 
2021-06-01
2.5
10
4
 56,169 
 98,419 
2021-03-01
0.9231
24
26
 463,051 
 82,096 
2020-12-01
0.4118
7
17
 426,175 
 868,904 
2020-09-01
0.6667
2
3
 58,595 
 116,784 
2020-06-01
1.1176
19
17
 110,225 
 197,091 
2020-03-01
0.4833
29
60
 832,658 
 810,262 
2019-12-01
0.5556
5
9
 53,108 
 121,082 
2019-09-01
1.5
3
2
 5,575 
 10,000 
2019-06-01
0.7273
16
22
 440,723 
 933,661 
2019-03-01
0.675
27
40
 640,841 
 94,646 
2018-12-01
1.0
2
2
 1,582 
 1,775 
2018-09-01
0.4615
6
13
 132,909 
 270,528 
2018-06-01
1.8571
13
7
 245,797 
 470,394 
2018-03-01
0.4844
31
64
 818,373 
 615,774 
2017-12-01
1.0
1
1
 330.00 
 9.00 
2017-09-01
0.6957
16
23
 106,739 
 217,026 
2017-06-01
0.8696
20
23
 244,698 
 379,799 
2017-03-01
0.6154
32
52
 793,137 
 388,902 
2016-12-01
0.6364
7
11
 34,791 
 76,976 
2016-09-01
0.4
8
20
 15,022 
 38,521 
2016-06-01
1.0
19
19
 207,033 
 378,361 
2016-03-01
0.9688
31
32
 768,157 
 37,464 
2015-12-01
2.0
2
1
 2,096 
 1,188 
2015-09-01
0.5
4
8
 3,393 
 23,223 
2015-06-01
6.5
13
2
 28,727 
 7,281 
2015-03-01
0.7353
25
34
 691,591 
 87,591 
2014-12-01
0.7333
11
15
 205,270 
 408,580 
2014-09-01
0.5882
10
17
 86,423 
 164,420 
2014-06-01
1.1667
14
12
 69,984 
 93,506 
2014-03-01
0.931
27
29
 718,279 
 269,116 
2013-12-01
0.4286
6
14
 56,247 
 119,566 
2013-09-01
0.8
8
10
 183,792 
 181,685 
2013-06-01
1.4737
28
19
 241,052 
 347,934 
2013-03-01
0.7143
25
35
 561,099 
 76,957 
2012-12-01
0.6667
2
3
 47,446 
 93,573 
2012-09-01
0.5833
14
24
 272,457 
 526,735 
2012-06-01
1.25
30
24
 403,796 
 246,935 
2012-03-01
0.6531
32
49
 865,372 
 1,070,734 
2011-12-01
0.7
14
20
 292,360 
 509,980 
2011-09-01
0.4
2
5
 34,175 
 69,850 
2011-06-01
0.5294
9
17
 85,923 
 369,672 
2011-03-01
0.5641
22
39
 609,985 
 579,316 
2010-06-01
6.0
6
1
 29,001 
 1,173 
2010-03-01
0.8
16
20
 545,439 
 366,685 
2009-12-01
0.4
2
5
 18,407 
 62,637 
2009-09-01
0.6667
6
9
 234,236 
 358,472 
2009-03-01
0.9565
22
23
 360,097 
 150,876 
2008-12-01
0.6667
4
6
 120,232 
 201,935 
2008-03-01
2.3333
7
3
 248,579 
 6,287 
2007-06-01
2.75
11
4
 37,381 
 2,092 
2007-03-01
1.1351
42
37
 687,049 
 339,277 
2006-12-01
1.5
6
4
 103,482 
 204,000 
2006-06-01
1.7273
19
11
 209,261 
 273,253 
2006-03-01
1.8571
13
7
 576,413 
 127,414 
2005-09-01
1.6667
10
6
 46,667 
 59,999 
2005-06-01
1.0
8
8
 53,015 
 67,700 
2005-03-01
1.2222
11
9
 266,899 
 219,476 
2004-12-01
0.4516
14
31
 276,225 
 572,270 
2004-09-01
0.4048
17
42
 335,140 
 687,500 
2004-06-01
0.6667
28
42
 372,751 
 668,767 
2004-03-01
0.5676
21
37
 511,883 
 594,113 
2003-12-01
0.6471
11
17
 132,988 
 293,520 
2003-09-01
0.875
7
8
 21,513 
 27,052 

Quest Diagnostics Notable Stakeholders

A Quest Diagnostics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Quest Diagnostics often face trade-offs trying to please all of them. Quest Diagnostics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Quest Diagnostics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Stephen RusckowskiCEO and President Director and Member of Executive CommitteeProfile
Daniel StanzioneNon-Executive Chairman of the BoardProfile
Michael PrevoznikSenior Vice President General CounselProfile
Catherine DohertySenior Vice President, Group Executive - Clinical Franchise Solutions and MarketingProfile
Gabrielle WolfsonSenior Vice President and Chief Information and Digital OfficerProfile
Carrie MannerSenior Vice President - Advanced DiagnosticsProfile
Michael DeppeVice President Corporate Controller and Chief Accounting Officer and Principal Accounting OfficerProfile
Mark GuinanChief Financial Officer, Executive Vice PresidentProfile
James DavisExecutive Vice President, General DiagnosticsProfile
Sam SamadExecutive CFOProfile
Gail WilenskyIndependent DirectorProfile
Wright LassiterIndependent DirectorProfile
Gary PfeifferIndependent DirectorProfile
Vicky GreggIndependent DirectorProfile
Helen TorleyIndependent DirectorProfile
Shawn BevecExecutive Director Investor RelationsProfile
Timothy MainIndependent DirectorProfile
Denise MorrisonIndependent DirectorProfile
Timothy RingLead Independent DirectorProfile
Murali BalakumarChief VPProfile
Patrick PlewmanSenior ServicesProfile
Kristin EsqSenior OfficerProfile
Cecilia McKenneySenior OfficerProfile
Tracey DoiIndependent DirectorProfile
Karthik KuppusamySenior SolutionsProfile
Manuel MendezSenior Vice President Chief Commercial OfficerProfile
Dermot ShortenMA StrategyProfile
Gary SamuelsSenior OfficerProfile
Michael JDSenior CounselProfile

About Quest Diagnostics Management Performance

The success or failure of an entity such as Quest Diagnostics often depends on how effective the management is. Quest Diagnostics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Quest management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Quest management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.17  0.14 
Return On Capital Employed 0.10  0.10 
Return On Assets 0.06  0.04 
Return On Equity 0.14  0.08 
Please note, the imprecision that can be found in Quest Diagnostics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Quest Diagnostics Incorporated. Check Quest Diagnostics' Beneish M Score to see the likelihood of Quest Diagnostics' management manipulating its earnings.

Quest Diagnostics Workforce Analysis

Traditionally, organizations such as Quest Diagnostics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Quest Diagnostics within its industry.

Quest Diagnostics Manpower Efficiency

Return on Quest Diagnostics Manpower

Revenue Per Employee185K
Revenue Per Executive319M
Net Income Per Employee17K
Net Income Per Executive29.3M
Working Capital Per Employee11.1K
Working Capital Per Executive19.2M

Additional Tools for Quest Stock Analysis

When running Quest Diagnostics' price analysis, check to measure Quest Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Quest Diagnostics is operating at the current time. Most of Quest Diagnostics' value examination focuses on studying past and present price action to predict the probability of Quest Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Quest Diagnostics' price. Additionally, you may evaluate how the addition of Quest Diagnostics to your portfolios can decrease your overall portfolio volatility.